# Church & Dwight Co Inc: Form 10-Q for the period ended Sep 30, 2013

- Company: [Church & Dwight Co Inc](/companies/chd.md) (CIK 313927)
- Form: 10-Q
- Filed: 2013-11-01
- Accepted by EDGAR: Nov 1, 2013, 16:32 ET
- Period: 2013-09-30
- Accession: 0001193125-13-422487
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/313927/000119312513422487/d587021d10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/313927/000119312513422487/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2013-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2013-07-01 to 2013-09-30 | $804.8m | us-gaap:SalesRevenueGoodsNet |
| Revenue | 9 months, 2013-01-01 to 2013-09-30 | $2.37bn | us-gaap:SalesRevenueGoodsNet |
| Cost of revenue | 3 months, 2013-07-01 to 2013-09-30 | $439.6m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 9 months, 2013-01-01 to 2013-09-30 | $1.31bn | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2013-07-01 to 2013-09-30 | $365.2m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2013-01-01 to 2013-09-30 | $1.07bn | us-gaap:GrossProfit |
| Research and development | 3 months, 2013-07-01 to 2013-09-30 | $16.3m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2013-01-01 to 2013-09-30 | $45.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2013-07-01 to 2013-09-30 | $97.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2013-01-01 to 2013-09-30 | $306.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2013-07-01 to 2013-09-30 | $167.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2013-01-01 to 2013-09-30 | $477.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2013-07-01 to 2013-09-30 | $7.0m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2013-01-01 to 2013-09-30 | $21.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2013-07-01 to 2013-09-30 | $55.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2013-01-01 to 2013-09-30 | $156.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 9 months, 2013-01-01 to 2013-09-30 | $302.2m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months, 2013-07-01 to 2013-09-30 | $0.76 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2013-01-01 to 2013-09-30 | $2.14 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2013-07-01 to 2013-09-30 | $0.78 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2013-01-01 to 2013-09-30 | $2.18 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2013-07-01 to 2013-09-30 | 141,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2013-01-01 to 2013-09-30 | 141,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2013-01-01 to 2013-09-30 | $376.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2013-01-01 to 2013-09-30 | $30.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2013-01-01 to 2013-09-30 | $116.3m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months, 2013-01-01 to 2013-09-30 | $50.3m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2013-09-30 | $445.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2013-09-30 | $1.07bn | us-gaap:AssetsCurrent |
| Total assets | at 2013-09-30 | $4.20bn | us-gaap:Assets |
| Current liabilities | at 2013-09-30 | $640.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2013-09-30 | $1.97bn | us-gaap:Liabilities |
| Long-term debt | at 2013-09-30 | $649.5m | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | at 2013-09-30 | $154.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2013-09-30 | $2.23bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 26,682 characters.

### Results of Operations

### Consolidated Results

#### Net Sales

Net sales for the quarter ended September 30, 2013 were $804.8 million, an increase of $79.6 million or 11.0% over the third quarter of 2012. Net sales for the nine months ended September 30, 2013 were $2,371.7 million, an increase of $259.5 million or 12.3% over the comparable nine month period of 2012. The components of the net sales increase are the following:

| Net Sales - Consolidated | Three Months Ended September 30, 2013 | Nine Months Ended September 30, 2013 |
| --- | ---: | ---: |
| Product volumes sold | 4.7% | 3.3% |
| Pricing/Product mix | (3.1%) | (1.5%) |
| Foreign exchange rate fluctuations | (0.8%) | (0.5%) |
| Acquired product lines(1) | 10.2% | 10.5% |
| Sales in anticipation of information systems upgrade | 0.0% | 0.5% |
| **Net Sales increase** | **11.0%** | **12.3%** |

(1) On October 1, 2012, Church & Dwight Co., Inc. ( the “Company”) acquired Avid Health, Inc. (“Avid Health”). Net sales of the acquired product lines subsequent to the acquisition are included in the Company’s results.

For the three months ended September 30, 2013, the volume change primarily reflects increased sales of products in all segments. Unfavorable product mix and pricing in Consumer Domestic and in SPD had an impact on total net sales. For the nine months ended September 30, 2013, the increase in volume was due to increased product sales in the Consumer Domestic and Consumer International segments partially offset by lower SPD volumes. Sales in the first quarter of 2012 were negatively impacted due to a timing shift in customer orders from the first quarter of 2012 to the fourth quarter of 2011 in anticipation of the January 1, 2012 information systems upgrade in the U.S.

#### Operating Costs

The Company’s gross profit was $365.2 million for the quarter ended September 30, 2013, a $37.7 million increase as compared to the same period in 2012. The gross profit increase was primarily attributable to contributions from the acquired product lines, higher sales volumes and productivity improvement programs, partially offset by higher trade promotion and coupon costs and unfavorable product mix. The Company’s gross profit was $1,066.3 million for the nine month period ended September 30, 2013, a $133.3 million increase as compared to the same period in 2012 due primarily to contributions from the acquired product lines, higher sales volume and productivity improvement programs. These increases were partially offset by higher trade promotion and an unfavorable product mix. Commodity costs were flat in the three and nine month periods ended September 30, 2013 as compared to the same periods in 2012.

Gross margin increased 20 basis points to 45.4% in the third quarter of 2013 as compared to 45.2% in the same quarter in 2012, and 80 basis points to 45.0% in the first nine months of 2013 as compared to 44.2% in the same period of 2012. Gross margin was higher due to the positive impact of productivity improvement programs and higher sales volume, partially offset by higher trade promotion and coupon costs and unfavorable product mix.

Marketing expenses for the third quarter of 2013 were $99.7 million, an increase of $7.5 million as compared to the same period in 2012 due primarily to acquired product lines and higher spending in support of certain of its power brands. Marketing expenses as a percentage of net sales were 12.4% in the third quarter of 2013 as compared to 12.7% in the same period in 2012. Marketing expenses for the first nine months of 2013 were $282.3 million, an increase of $33.7 million as compared to the same period in 2012 due primarily to the same factors as those applicable to the third quarter of 2013. Marketing expenses as a percentage of net sales were 11.9% in the first nine months of 2013 as compared to 11.8% in the same period in 2012.

Selling, general and administrative expenses (“SG&A”) were $97.7 million in the third quarter of 2013, an increase of $7.8 million as compared to the same period in 2012 which included operating costs associated with the Avid Health acquisition and higher research and development (“R&D”) costs. SG&A for the first nine months of 2013 were $306.4 million, an increase of $32.5 million as compared to the same period in 2012 due primarily to operating costs associated with the Avid Health acquisition, higher R&D and compensation costs, partially offset by lower legal expenses. SG&A as a percentage of net sales was 12.1% in the third quarter of 2013 as compared to 12.4% in the third quarter of 2012. SG&A as a percentage of net sales was 12.9% in the first nine months of 2013 as compared to 13.0% in the same period in 2012.

#### Other Income and Expenses

Equity in earnings (losses) of affiliates decreased by $0.5 million and $5.9 million for the three and nine month periods ended September 30, 2013, respectively, as compared to the same periods in 2012. The decrease is due primarily to an impairment charge recorded in the second quarter of 2013 associated with one of the Company’s affiliates and lower earnings from Armand Products Company (“Armand”) as a result of increased raw material costs.

Interest expense in the three and nine month periods ended September 30, 2013 increased $4.4 million and $13.3 million, respectively, compared to the same periods in 2012 primarily due to the debt incurred to finance the acquisition of Avid Health.

#### Taxation

The effective tax rate in the three and nine month periods ended September 30, 2013 was 33.9% and 34.1%, respectively, compared to 35.7% and 34.8%, respectively, in the same periods in 2012. The effective tax rate in the third quarter of 2013 was favorably affected by an effective state tax rate decrease and an increase in the U.S. manufacturing deduction when compared with the same period in 2012. The effective tax rate for the nine month period ended September 30, 2013 was favorably affected by an effective state tax rate decrease and a tax benefit relating to the retroactive extension of a research tax credit that occurred in the first quarter of 2013. The 2013 annual effective tax rate is projected to be approximately 34%.

### Segment results

The Company operates three reportable segments: Consumer Domestic, Consumer International and Specialty Products Division (“SPD”). These segments are determined based on differences in the nature of products and organizational and ownership structures. The Company also has a Corporate segment.

| Segment | Products |
| --- | --- |
| Consumer Domestic | Household and personal care products |
| Consumer International | Primarily personal care products |
| SPD | Specialty chemical products |

The Corporate segment income consists of equity in earnings (losses) of affiliates. As of September 30, 2013, the Company had a 50% ownership interest in each of Armand and The ArmaKleen Company (“ArmaKleen”), respectively, and a one-third ownership interest in Natronx Technologies, LLC (“Natronx”). The Company’s equity in earnings (losses) of Armand, ArmaKleen and Natronx for the three and nine months ended September 30, 2013 and September 30, 2012 are included in the Corporate segment.

Some of the subsidiaries that are included in the Consumer International segment manufacture and sell personal care products to the Consumer Domestic segment. These sales are eliminated from the Consumer International segment results set forth below.

Segment Net Sales and Income before Income Taxes for the three and nine month periods ended September 30, 2013 and September 30, 2012 were as follows:

*(In millions)*

| Net Sales(1) | Consumer Domestic | Consumer International | SPD | Corporate(3) | Total |
| --- | ---: | ---: | ---: | ---: | ---: |
| **Third Quarter 2013** | **$605.3** | **$134.5** | **$65.0** | **$0.0** | **$804.8** |
| Third Quarter 2012 | 530.4 | 131.1 | 63.7 | 0.0 | 725.2 |
| **First Nine Months of 2013** | **$1,790.8** | **$396.5** | **$184.4** | **$0.0** | **$2,371.7** |
| First Nine Months of 2012 | 1,547.5 | 373.8 | 190.9 | 0.0 | 2,112.2 |
| **Income Before Income Taxes(2)** |  |  |  |  |  |
| **Third Quarter 2013** | **$136.0** | **$15.5** | **$9.8** | **$1.9** | **$163.2** |
| Third Quarter 2012 | 116.6 | 16.0 | 11.0 | 2.4 | 146.0 |
| **First Nine Months of 2013** | **$383.2** | **$53.0** | **$21.0** | **$1.4** | **$458.6** |
| First Nine Months of 2012 | 324.9 | 52.6 | 27.5 | 7.3 | 412.3 |

(1) Intersegment sales from Consumer International to Consumer Domestic were $0.7 million and $0.1 million for the quarters ended September 30, 2013 and September 30, 2012, respectively, and were $1.9 million and $1.9 million for the nine months ended September 30, 2013 and September 30, 2012, respectively.

(2) In determining Income before Income Taxes, interest expense, investment earnings and other income (expense) were allocated among the segments based upon each segment’s relative operating profit.

(3) Corporate consists of equity in earnings (losses) of affiliates from Armand, ArmaKleen and Natronx.

Product line revenues for external customers for the three and nine month periods ended September 30, 2013 and September 30, 2012 were as follows:

*(In millions)*

|  | Three Months Ended September 30, 2013 | September 30, 2012 | Nine Months Ended September 30, 2013 | September 30, 2012 |
| --- | ---: | ---: | ---: | ---: |
| Household Products | **$369.0** | $360.4 | **$1,081.8** | $1,054.2 |
| Personal Care Products | **236.3** | 170.0 | **709.0** | 493.3 |
| Total Consumer Domestic | **605.3** | 530.4 | **1,790.8** | 1,547.5 |
| Total Consumer International | **134.5** | 131.1 | **396.5** | 373.8 |
| Total SPD | **65.0** | 63.7 | **184.4** | 190.9 |
| **Total Consolidated Net Sales** | **$804.8** | $725.2 | **$2,371.7** | $2,112.2 |

Household Products include deodorizing, cleaning and laundry products. Personal Care Products include condoms, pregnancy kits, oral care products, skin care products and vitamin and mineral supplements.

### Consumer Domestic

Consumer Domestic net sales in the third quarter of 2013 were $605.3 million, an increase of $74.9 million or 14.1% compared to the third quarter of 2012. Consumer Domestic net sales for the nine months ended September 30, 2013 were $1,790.8 million, an increase of $243.3 million or 15.7% as compared to the same period in 2012. The components of the net sales change are the following:

| Net Sales - Consumer Domestic | Three Months Ended September 30, 2013 | Nine Months Ended September 30, 2013 |
| --- | ---: | ---: |
| Product volumes sold | 4.5% | 3.6% |
| Pricing/Product mix | (3.7%) | (2.1%) |
| Acquired product lines(1) | 13.3% | 13.6% |
| Sales in anticipation of information systems upgrade | 0.0% | 0.6% |
| **Net Sales increase** | **14.1%** | **15.7%** |

(1) On October 1, 2012, the Company acquired Avid Health. Net sales of acquired product lines subsequent to the acquisition are included in Consumer Domestic results.

In the third quarter of 2013, the increase in net sales reflects sales from the acquired product lines and higher sales of ARM & HAMMER liquid laundry detergent, OXICLEAN laundry additives, TROJAN products and FIRST RESPONSE diagnostic kits. These increases were partially offset by lower sales of ARM & HAMMER powder laundry detergent and ARM & HAMMER cat litter, NAIR depilatories and SPINBRUSH battery–operated toothbrushes. The increase in net sales for the nine months ended September 30, 2013 reflects sales from the acquired product lines and higher sales of ARM & HAMMER liquid laundry detergent, OXICLEAN laundry additives, TROJAN products and FIRST RESPONSE diagnostic kits, partially offset by sales declines in ARM & HAMMER powder laundry detergent, SPINBRUSH battery-operated toothbrushes, XTRA liquid laundry detergent, NAIR depilatories and KABOOM household cleaners. Sales in the first quarter of 2012 were negatively impacted due to a timing shift in customer orders from the first quarter of 2012 to the fourth quarter of 2011 in anticipation of the January 1, 2012 information systems upgrade in the U.S.

Since the 2012 introduction in the United States of unit dose laundry detergent by various manufacturers, including the Company, there has been significant product and price competition in the laundry detergent category, contributing to an overall category decline. During the third quarter of 2013 the category declined an additional 3.5%. While the Company’s laundry detergent sales have increased, more than offsetting the impact of the total laundry detergent category decline, there is no assurance that the category will not decline further or that the Company will be able to offset any such category decline. The Procter & Gamble Company (“P&G”), one of the Company’s major competitors and the market leader in premium laundry detergent, has announced that in 2014 it will launch a lower-priced laundry detergent that may compete directly with the Company’s core value laundry detergents. This, together with expected ongoing weak consumer spending and increased price competition, could negatively impact the Company’s laundry detergent business. The Company plans to vigorously combat these pressures through, among other things, significant new product introductions supported by increased marketing spending. There can be no assurance that these measures will be successful.

Consumer Domestic income before income taxes for the third quarter of 2013 was $136.0 million, a $19.4 million increase as compared to the third quarter of 2012. The increase is due primarily to the contribution from the Avid Health acquisition (net of higher interest expense), the impact of higher sales volumes, and lower manufacturing costs resulting from productivity improvement projects, partially offset by higher trade promotion and coupon costs, the effect of unfavorable product mix and higher marketing and SG&A expenses. For the nine month period ended September 30, 2013, income before income taxes was $383.2 million, a $58.3 million increase as compared to the first nine months of 2012 due primarily to the same factors as the third quarter of 2013.

### Consumer International

Consumer International net sales were $134.5 million in the third quarter of 2013, an increase of $3.4 million or 2.6% as compared to the same period in 2012. Consumer International net sales in the first nine months of 2013 were $396.5 million, an increase of $22.7 million or 6.1% as compared to the same period in 2012. The components of the net sales change are the following:

| Net Sales - Consumer International | Three Months Ended September 30, 2013 | Nine Months Ended September 30, 2013 |
| --- | ---: | ---: |
| Product volumes sold | 3.7% | 4.2% |
| Pricing/Product mix | 0.0% | 0.8% |
| Foreign exchange rate fluctuations | (3.4%) | (1.9%) |
| Acquired product lines(1) | 2.3% | 3.0% |
| **Net Sales increase** | **2.6%** | **6.1%** |

(1) On October 1, 2012, the Company acquired Avid Health. Net sales of acquired product lines subsequent to the acquisition are included in the Consumer International results.

Higher sales volumes in the third quarter of 2013 occurred primarily in Mexico, France, Canada and Brazil. Higher sales volumes in the first nine months of 2013 occurred primarily in Mexico, Brazil, United Kingdom, Canada, France, Australia and U.S. exports.

Consumer International income before income taxes was $15.5 million in the third quarter of 2013, a decrease of $0.5 million compared to the same period in 2012. The change is due primarily to the effect of changes in foreign exchange rates, partially offset by higher sales volume. For the first nine months of 2013, income before income taxes was $53.0 million, a $0.4 million increase as compared to the same period of 2012, due primarily to higher sales volume, favorable price/product mix and the contribution from the Avid Health acquisition, partially offset by the effect of changes in foreign exchange rates and higher SG&A.

### Specialty Products

SPD net sales were $65.0 million for the third quarter of 2013, an increase of $1.3 million or 2.0% as compared to the same period in 2012. SPD net sales were $184.4 million for the first nine months of 2013, a decrease of $6.5 million, or 3.4% as compared to the same period in 2012. The components of the net sales change are the following:

| Net Sales - SPD | Three Months Ended September 30, 2013 | Nine Months Ended September 30, 2013 |
| --- | ---: | ---: |
| Product volumes sold | 7.9% | (1.5%) |
| Pricing/Product mix | (4.2%) | (1.1%) |
| Foreign exchange rate fluctuations | (1.7%) | (1.3%) |
| Sales in anticipation of information systems upgrade | 0.0% | 0.5% |
| **Net Sales increase (decrease)** | **2.0%** | **(3.4%)** |

The net sales increase in the third quarter of 2013 reflects higher animal nutrition and bulk chemical product sales volumes offset by lower pricing in animal nutrition products. The decrease in net sales for the nine months ended September 30, 2013 is due primarily to colder than normal weather during the second quarter, which impacted demand from the dairy industry, and to lower sales in Brazil. In addition, the decrease in net sales for the nine months is offset by the adverse impact in the first quarter of 2012 of a timing shift in customer orders from the first quarter of 2012 to the fourth quarter of 2011 in anticipation of the January 1, 2012 information systems upgrade in the U.S.

SPD income before income taxes was $9.8 million in the third quarter of 2013, a decrease of $1.2 million as compared to the same period in 2012, and $21.0 million for the first nine months of 2013, a decrease of $6.5 million as compared to the same period in 2012. The decrease in income before income taxes for the third quarter of 2013 is due primarily to lower selling prices for animal nutrition products. The decrease in income before income taxes for the first nine months of 2013 is due primarily to the same factors as those applicable to the third quarter of 2013.

### Corporate

The reduction in profitability within the Corporate segment for the nine month period ended September 30, 2013 is primarily due to a $3.2 million impairment charge associated with one of the Company’s investment in affiliates recorded in the second quarter of 2013. The charge is the result of the Company’s assessment of the financial impact of the delay in anticipated discounted cash flows from the affiliate.

### Liquidity and Capital Resources

As of September 30, 2013, the Company had $445.5 million in cash, approximately $350 million available through its revolving credit facility under its principal credit agreement (the “Credit Agreement”) and its commercial paper program, and a commitment increase feature under the Credit Agreement that enables the Company to borrow up to an additional $500 million, subject to lending commitments of the participating lenders and certain conditions as described in the Credit Agreement. To preserve its liquidity, the Company invests its cash primarily in prime money market funds and short term bank deposits.

As of September 30, 2013, the amount of cash and cash equivalents included in the Company’s assets, that was held by foreign subsidiaries was approximately $190.1 million. If these funds are needed for operations in the U.S., the Company will be required to accrue and pay taxes in the U.S. to repatriate these funds. However, the Company’s intent is to permanently reinvest these funds outside the U.S., and the Company does not currently expect to repatriate them to fund operations in the U.S.

The current economic environment presents risks that could have adverse consequences for the Company’s liquidity. (See “Unfavorable economic conditions could adversely affect demand for our products” under “Risk Factors” in Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2012 (the “Form 10-K”).) The Company does not anticipate that current economic conditions will adversely affect its ability to comply with the financial covenants under the Credit Agreement because the Company currently is, and anticipates that it will continue to be, in compliance with the minimum interest coverage ratio requirement and the maximum leverage ratio requirement under the Credit Agreement. These financial ratios are discussed in more detail in this section under “Certain Financial Covenants.”

On January 30, 2013, the Board of Directors increased the Company’s regular quarterly dividend from $0.24 per share to $0.28 per share of common stock of the Company (“Common Stock”), equivalent to an annual dividend rate of $1.12 per share, commencing with the dividend payable on March 1, 2013 to stockholders of record at the close of business on February 15, 2013. The higher quarterly dividend raises the Company’s annualized dividend payout from approximately $135 million to approximately $156 million.

In January 2013, the Company purchased approximately 0.9 million shares of Common Stock at an aggregate cost of approximately $50 million under its share repurchase program. The Company did not repurchase any Common Stock in the second or third quarters of 2013.

The Company anticipates that its cash from operations, together with its current borrowing capacity, will be sufficient to meet its capital expenditure program costs, which are expected to be approximately $70 million in 2013, fund its Common Stock repurchase program to the extent implemented by management and pay dividends at the latest approved rate. Cash may be used for acquisitions that would complement the Company’s existing product lines or geographic markets.

#### Net Debt

The Company had outstanding total debt of $803.5 million and cash of $445.5 million at September 30, 2013, resulting in net debt of $358.0 million at September 30, 2013. This compares to total debt of $903.2 million and cash of $343.0 million, resulting in net debt of $560.2 million at December 31, 2012. Net debt is defined as total debt less cash.

#### Cash Flow Analysis

*(In millions)*

|  | Nine Months Ended September 30, 2013 | September 30, 2012 |
| --- | ---: | ---: |
| Net cash provided by operating activities | **$376.6** | $315.9 |
| Net cash used in investing activities | **$(39.1)** | $(711.0) |
| Net cash (used in) provided by financing activities | **$(230.0)** | $381.3 |

**Net Cash Provided by Operating Activities –** The Company’s net cash provided by operating activities in the first nine months of 2013 increased $60.7 million to $376.6 million as compared to the same period in 2012. The increase is due to higher net income and increases in accounts payable, offset by changes in accounts receivable and inventories. The Company was also able to defer its fourth quarter 2012 federal tax payment of approximately $36.0 million to the first quarter of 2013 as allowed by the IRS due to the impact of Hurricane Sandy, which offset the increase in net cash provided by operating activities in the first nine months of 2013.

**Net Cash Used in Investing Activities –** Net cash used in investing activities during the first nine months of 2013 was $39.1 million, reflecting $30.3 million of property, plant and equipment expenditures and a $5.7 million investment in Natronx.

**Net Cash Used in Financing Activities –** Net cash used in financing activities during the first nine months of 2013 was $230.0 million, primarily reflecting $100.0 million of repayments of commercial paper, $50.3 million of repurchases of Common Stock and $116.3 million of cash dividends, partially offset by $26.0 million of proceeds and tax benefits from stock option exercises and the receipt of an incentive payment of $10.9 million related to the financing lease for the Company’s new corporate headquarters.

### Certain Financial Covenants

“Consolidated EBITDA” (referred to below as “Adjusted EBITDA” and defined in the Credit Agreement) is a component of the financial covenants contained in the Credit Agreement. Such financial covenants include a leverage ratio (total debt to Adjusted EBITDA) and an interest coverage ratio (Adjusted EBITDA to total interest expense), which, if not met, could result in an event of default and trigger the early termination of the Credit Agreement. Adjusted EBITDA may not be comparable to similarly titled measures used by other entities and should not be considered as an alternative to cash flows from operating activities determined in accordance with accounting principles generally accepted in the U.S. The Company’s leverage ratio for the twelve months ended September 30, 2013 was 1.2, which is below the maximum of 3.5 permitted under the Credit Agreement, and the interest coverage ratio for the twelve months ended September 30, 2013 was 36.4, which is above the minimum of 3.0 permitted under the Credit Agreement.

### New Accounting Pronouncements

During the first quarter of 2013, the Financial Accounting Standards Board (“FASB”) issued guidance for the reporting of amounts reclassified out of accumulated other comprehensive income. The guidance requires an entity to present information about significant items reclassified out of accumulated other comprehensive income either on the face of the statement where net income is presented or as a separate disclosure in the notes to the financial statements. The Company elected to present the requirements in the notes to the financial statements (see Note 12). The adoption of the new pronouncement did not have a material impact on the Company’s consolidated financial position, results of operations or cash flows.

In July 2013, the FASB issued guidance requiring an entity to net its liability for unrecognized tax benefits against the deferred tax assets for all same jurisdiction net operating losses or similar tax loss carryforwards, or tax credit carryforwards. A gross presentation will be required only if such carryforwards are not available as of reporting date to settle any additional income taxes resulting from disallowance of the uncertain tax position or the entity does not intend to use these carryforwards for this purpose. The new guidance is effective on a prospective basis for fiscal years beginning after December 15, 2013 and interim periods within those years. This new guidance is not expected to have a material impact on the Company’s consolidated financial position, results of operations or cash flows.

There have been no other accounting pronouncements issued but not yet adopted by the Company which are expected to have a material impact on the Company’s consolidated financial position, results of operations or cash flows.

## Market risk

As filed, 3,241 characters.

### Market risk

#### Interest Rate Risk

The Company had outstanding total debt at September 30, 2013 of $803.5 million, of which 81% has a fixed weighted average interest rate of 3.06% and the remaining 19% constituted primarily commercial paper issued by the Company that currently has an interest rate of less than 0.4%. The Company periodically considers entering into derivative financial instruments contracts to reduce interest rate risk exposure.

#### Diesel Fuel Hedge

The Company uses independent freight carriers to deliver its products. These carriers charge the Company a basic rate per mile that is subject to a mileage surcharge for diesel fuel price increases. During 2012 and 2013, the Company entered into hedge agreements with financial counterparties to mitigate the volatility of diesel fuel prices and related fuel surcharges, and not to speculate in the future price of diesel fuel. Under the hedge agreements, the Company agreed to pay a fixed price per gallon of diesel fuel determined at the time the agreements were executed and to receive a floating rate payment reflecting the variable common carriers’ mileage surcharge. The floating rate payment is determined on a monthly basis based on the average price of the Department of Energy’s Diesel Fuel Index during the applicable month and is designed to offset any increase or decrease in fuel surcharges that the Company pays to it common carriers. As of September 30, 2013, the agreements are expected to cover approximately 45% of the Company’s estimated diesel fuel requirements for 2013 and approximately 28% of the Company’s estimated diesel fuel requirements for 2014. These diesel fuel hedge agreements qualify for hedge accounting. Therefore, changes in the fair value of such agreements are recorded under Accumulated Other Comprehensive Income on the balance sheet.

#### Foreign Currency

The Company is subject to exposure from fluctuations in foreign currency exchange rates, primarily U.S. Dollar/Euro, U.S. Dollar/British Pound, U.S. Dollar/Canadian Dollar, U.S. Dollar/Mexican Peso, U.S. Dollar/Australian Dollar, U.S. Dollar/Brazilian Real and U.S. Dollar/Chinese Yuan.

The Company, from time to time, enters into forward exchange contracts to reduce the impact of foreign exchange rate fluctuations related to anticipated but not yet committed intercompany sales or purchases denominated in U.S. Dollar,

Canadian Dollar, British Pound and Euro. The Company has entered into forward exchange contracts to protect itself from the risk that, due to fluctuations in currency exchange rates, it would be adversely affected by net cash outflows.

#### Equity Derivatives

The Company has entered into equity derivative contracts covering its Common Stock in order to minimize its liability under its Executive Deferred Compensation Plan resulting from changes in the quoted fair values of its Common Stock to participants who have investments under the Plan in a notional Common Stock fund. The contracts are settled in cash. Since the equity derivatives contracts do not qualify for hedge accounting, the Company is required to mark such contracts to market throughout their lives and record changes in fair value in the consolidated statement of income.

## Controls and procedures

As filed, 4,965 characters.

a) Evaluation of Disclosure Controls and Procedures

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) at the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures as of the end of the period covered by this report are effective to provide reasonable assurance that the information required to be disclosed by the Company in reports filed under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the U.S. Securities and Exchange Commission’s (the “Commission”) rules and forms, and (ii) accumulated and communicated to the Company’s management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding the disclosure.

b) Change in Internal Control over Financial Reporting

No change in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the Company’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

### CAUTIONARY NOTE ON FORWARD-LOOKING INFORMATION

This report contains forward-looking statements, including, among others, statements relating to sales and earnings growth; the effect of product mix; volume growth, including the effects of new products; the impact of unit dose laundry detergent; impairment of an affiliated company; consumer demand and spending; the effects of competition; earnings per share; gross margin changes; trade and marketing spending; marketing expense as a percentage of net sales; cost savings programs; the Company’s hedge programs; the impact of foreign exchange and commodity price fluctuations; the Company’s Common Stock repurchase programs; the impact of acquisitions including the acquisition of Avid Health; capital expenditures; the sales impact related to the Company’s information systems upgrade; the effective tax rate; the impact of tax audits; tax changes and the lapse of applicable statutes of limitations; facility restructuring charges; environmental and regulatory matters; availability of raw materials; the effect of the credit environment on the Company’s liquidity and capital expenditures; the Company’s fixed rate debt; compliance with the minimum interest coverage ratio requirement and the maximum leverage ratio requirement under the Company’s credit agreement; the Company’s commercial paper program; sufficiency of cash flows from operations; the Company’s current and anticipated future borrowing capacity to meet capital expenditure program costs; payment of dividends; expected cash contributions to pension plans; investments in the Natronx joint venture; and adequacy of trona reserves. These statements represent the intentions, plans, expectations and beliefs of the Company, and are subject to risks, uncertainties and other factors, many of which are outside the Company’s control and could cause actual results to differ materially from such forward-looking statements. Factors that might cause such differences include a decline in market growth and consumer demand (as a result of, among other things, political, economic and marketplace conditions and events); unanticipated increases in raw material and energy prices; adverse developments affecting the financial condition of major customers and suppliers; competition; changes in marketing and promotional spending; growth or declines in various product categories and the impact of customer actions in response to changes in consumer demand and the economy, including increasing shelf space of private label products; consumer and competitor reaction to, and customer acceptance of, new product introductions and features; disruptions in the banking system and financial markets; foreign currency exchange rate fluctuations; the impact of natural disasters on the Company and its customers and suppliers, including third party information technology service providers; the acquisition or divestiture of assets; the outcome of contingencies, including litigation, pending regulatory proceedings and environmental matters; and changes in the regulatory environment.

The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the U.S. federal securities laws. You are advised, however, to consult any further disclosures we make on related subjects in the Company’s filings with the Commission.

## Risk factors

As filed, 252 characters.

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Item 1A, “Risk Factors” in the Form 10-K, which could materially affect the Company’s business, financial condition or future results.

Filed Nov 1, 2013.
Source: SEC EDGAR, the filing index for accession 0001193125-13-422487. Last ingested by Listed: Nov 14, 2026, 21:34 ET. No prices; not investment advice.
